News Articles Tagged: Non-24HSWD

The Therapeutic Journey of Tasimelteon: From Development to Clinical Application

Explore the development and clinical journey of Tasimelteon, a key melatonin receptor agonist. NINGBO INNO PHARMCHEM CO.,LTD. discusses its FDA approval for Non-24HSWD and its role in treating sleep disturbances.

Understanding Tasimelteon: A Melatonin Receptor Agonist for Sleep Regulation

Learn about Tasimelteon, its mechanism as a melatonin receptor agonist, and its applications in treating Non-24-Hour Sleep-Wake Disorder and Smith-Magenis Syndrome sleep disturbances. This article from NINGBO INNO PHARMCHEM CO.,LTD. explores its therapeutic benefits.